Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 695

1.

Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

Harris MI; National Health and Nutrition Examination Survey (NHANES III)..

Diabetes Care. 2001 Jun;24(6):979-82.

PMID:
11375356
2.

Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.

Hoffman RM, Shah JH, Wendel CS, Duckworth WC, Adam KD, Bokhari SU, Dalton C, Murata GH; Diabetes Outcome in Veterans Study..

Diabetes Care. 2002 Oct;25(10):1744-8.

PMID:
12351471
3.

Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES)..

Diabetes Care. 2003 Jun;26(6):1759-63.

PMID:
12766106
4.

Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.

Lecomte P, Romon I, Fosse S, Simon D, Fagot-Campagna A.

Diabetes Metab. 2008 Jun;34(3):219-26. doi: 10.1016/j.diabet.2007.11.005.

5.

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R.

Diabetes Obes Metab. 2006 Jan;8(1):58-66.

PMID:
16367883
6.

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group..

Diabetes Metab. 2003 Dec;29(6):587-94.

7.

Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.

Craig ME, Jones TW, Silink M, Ping YJ.

J Diabetes Complications. 2007 Sep-Oct;21(5):280-7.

PMID:
17825751
8.

The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies.

Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, Greenfield S, Kaplan SH, Sacco M, Tognoni G, Valentini M, Nicolucci A; QuED Study Group..

Diabetes Care. 2001 Nov;24(11):1870-7.

PMID:
11679449
9.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
11.
12.

The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.

Sarwat S, Ilag LL, Carey MA, Shrom DS, Heine RJ.

Diabet Med. 2010 May;27(5):589-92. doi: 10.1111/j.1464-5491.2010.02955.x.

PMID:
20536957
13.

Racial and ethnic differences in glycemic control of adults with type 2 diabetes.

Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS.

Diabetes Care. 1999 Mar;22(3):403-8.

14.
15.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
17.

[Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].

Schiel R, Müller UA, Stein G.

Med Klin (Munich). 2005 Aug 15;100(8):453-61. German.

PMID:
16096726
19.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
20.

Self-monitoring of blood glucose by adults with diabetes in the United States population.

Harris MI, Cowie CC, Howie LJ.

Diabetes Care. 1993 Aug;16(8):1116-23.

PMID:
8375241
Items per page

Supplemental Content

Support Center